Optiscan Imaging (OIL.AX) Saham Harga
Optiscan Imaging Harga
Pendapatan Optiscan Imaging menyusut 12,5% per tahun selama 19 tahun terakhir menjadi 448.769,00 AUD. margin bersih Optiscan Imaging saat ini -1.556,7%, turun dari -417,9% beberapa tahun lalu.
Harga saham Optiscan Imaging
Akses data ini lewat Eulerpool API
100.000 permintaan/bulan gratis · tanpa kartu
Model bisnis dan analisis saham Optiscan Imaging
Pertanyaan yang sering diajukan tentang saham Optiscan Imaging
The business model of Optiscan Imaging Ltd focuses on developing and commercializing advanced medical imaging technologies. The company specializes in the design and manufacture of confocal laser endomicroscopes, which are used in various medical applications. Optiscan Imaging aims to improve the diagnosis and treatment of diseases through their innovative imaging solutions. By leveraging their expertise in advanced imaging technologies, the company aims to provide healthcare professionals with high-quality and real-time cellular imaging during medical procedures. Optiscan Imaging Ltd's business model is centered around offering cutting-edge medical imaging technologies that deliver precise and detailed cellular imaging for improved patient outcomes.
Optiscan Imaging Ltd is primarily active in the medical technology and healthcare industries.
The main competitors of Optiscan Imaging Ltd in the market include companies such as Carl Zeiss Meditec AG, NIDEK CO., LTD., and Topcon Corporation.
Optiscan Imaging Ltd is a renowned company specializing in medical imaging technologies. Established in [year], Optiscan has achieved significant milestones in the field of diagnostic imaging. The company is known for its innovative optical imaging systems, such as confocal microscopy, which provide high-resolution cellular images for diagnostic purposes. Optiscan Imaging Ltd has a rich history of research and development, consistently striving to push the boundaries of medical imaging. With its advanced imaging solutions, Optiscan continues to contribute to the progression of healthcare.
Optiscan Imaging Ltd has achieved several significant milestones. The company successfully developed and patented a revolutionary confocal endomicroscopy technology, which enables real-time, high-resolution imaging of living tissue. Optiscan Imaging Ltd also received clearance from the U.S. Food and Drug Administration (FDA) for its confocal endomicroscopy system, facilitating its entry into the American market. Furthermore, the company collaborated with renowned medical institutions and researchers worldwide to conduct clinical studies and validate the efficacy of its imaging technology. Optiscan Imaging Ltd's relentless dedication to innovation and research has positioned it as a leader in the field of real-time tissue imaging.
Optiscan Imaging Ltd is primarily present in Australia.
Optiscan Imaging Ltd is a company known for its strong commitment to innovation and excellence in medical imaging. With a vision to improve patient outcomes, Optiscan prides itself on providing cutting-edge solutions for real-time cellular imaging. The company's corporate philosophy revolves around leveraging advanced technology to enhance diagnostic accuracy and enhance the effectiveness of medical procedures. Optiscan Imaging Ltd values integrity, collaboration, and a customer-centric approach, ensuring that their products and services meet the evolving needs of the medical community. By prioritizing research and development, Optiscan aims to revolutionize the field of medical imaging, while maintaining a steadfast dedication to quality and patient care.
Dengan kurs saat ini, saham Optiscan Imaging diperdagangkan pada 0,10 EUR (0,17 AUD).
Saham Optiscan Imaging (OIL.AX) tercatat di 1 bursa, termasuk: ASX (OIL.AX).
Optiscan Imaging Ltd is a leading provider of high-quality microscope systems and components for scientific research, medical diagnostics, and industrial testing and quality assurance. The company was founded in Melbourne, Australia in 1994 and has since expanded its operations worldwide. Today, Optiscan Imaging is a global company that delivers innovative technologies and products to meet the needs of its customers in various industries.
Pendapatan dari Optiscan Imaging adalah 448.769,00 AUD. Angka ini didasarkan pada data keuangan terkini dan mencerminkan kinerja bisnis perusahaan.
Laba dari Optiscan Imaging adalah -6,99 Juta. AUD. Laba bersih mencerminkan profitabilitas perusahaan setelah mengurangi semua biaya.
Rasio harga-terhadap-pendapatan (PER) Optiscan Imaging saat ini adalah -24,66. PER membandingkan harga saham saat ini dengan laba per saham dan membantu investor menilai valuasi saham Optiscan Imaging.
Rasio harga-terhadap-penjualan (PSR) Optiscan Imaging saat ini adalah 383,91. PSR membandingkan kapitalisasi pasar dengan pendapatan tahunan dan berfungsi sebagai metrik valuasi untuk saham Optiscan Imaging.
Skor Kualitas AlleAktien untuk Optiscan Imaging adalah 2/10.
ISIN dari Optiscan Imaging adalah AU000000OIL4. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.
WKN dari Optiscan Imaging adalah 932111. WKN (Wertpapierkennnummer) adalah kode identifikasi sekuritas Jerman enam digit.
Ticker dari Optiscan Imaging adalah OIL.AX. Simbol ticker digunakan untuk memperdagangkan saham Optiscan Imaging di bursa saham.
Saham Optiscan Imaging
Kelompok Peer Optiscan Imaging
Optiscan Imaging Ticker
Optiscan Imaging FIGI
Semua metrik fundamental dan analisis mendalam Optiscan Imaging
Analisis saham kami untuk saham Optiscan Imaging mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Optiscan Imaging. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.